Skip to main content
. Author manuscript; available in PMC: 2013 Sep 20.
Published in final edited form as: Eur Neurol Rev. 2012 Summer;7(2):134–139. doi: 10.17925/enr.2012.07.02.134

Table 1.

Boston Criteria for Cerebral Amyloid Angiopathy Diagnosis

1 Definite Cerebral Amyloid Angiopathy (CAA)

Full post-mortem examination demonstrating:
  • lobar, cortical or corticosubcortical haemorrhage

  • severe CAA with vasculopathy

  • absence of other diagnostic lesion


2 Probable CAA with Supporting Pathology

Clinical data and pathological tissue (evacuated haematoma or cortical biopsy) demonstrating:
  • lobar, cortical or corticosubcortical haemorrhage

  • some degree of CAA in specimen

  • absence of other diagnostic lesion


3 Probable CAA

Clinical data and MRI or CT demonstrating:
  • multiple haemorrhages restricted to lobar, cortical or corticosubcortical regions (cerebellar haemorrhage allowed)

  • age ≥55 years

  • absence of other cause of haemorrhage*


4 Possible CAA

Clinical data and MRI or CT demonstrating:
  • single lobar, cortical or corticosubcortical haemorrhage

  • age ≥55 years

  • absence of other cause of haemorrhage*

*

Other causes of intracerebral haemorrhage include: excessive warfarin dosing (international normalised ratio [INR] >3.0), antecedent head trauma or ischaemic stroke, central nervous system (CNS) tumour, vascular malformation, CNS vasculitis, blood dyscrasia, coagulopathy.

CT = computed tomography; MRI = magnetic resonance imaging.